DNA and RNA Aptamers Target Soluble IL-6 Receptor Effectively
The invention concerns DNA- and RNA-aptamers with high affinity and specificity for the human soluble IL-6-receptor with no or very low immunogenicity. These aptamers are very promising substances to treat or prevent diseases involving the IL-6-receptor, such as inflammation, cancer or infections. Furthermore, they can be easily and cost-efficiently produced and stored.
Further Information: PDF
Patent- und Verwertungsagentur für die Wissenschaftlichen Einrichtungen in Schleswig-Holstein GmbH (PVA SH)
Phone: +49 (0)431/8009937
Contact
Dr. Alexandra Baumgartner
